Heart health is often treated as a concern for adulthood. A new study suggests the conversation may need to start earlier.
In an observational study published in Pediatric Research, researchers in Finland found that certain blood markers related to lipid metabolism were associated with cognitive performance in adolescents. The study does not prove that cholesterol, triglycerides or fatty acids directly affect teen brain function. But it adds to evidence that cardiometabolic health and brain health may be connected well before adulthood.
The study included 251 adolescents ages 15 to 17 and examined links between blood-based metabolic biomarkers and cognitive function. Researchers found that higher concentrations of several markers tied to less favorable lipid profiles, including total cholesterol, LDL cholesterol, VLDL cholesterol, triglycerides and saturated fatty acids, were associated with slower processing speed during cognitive testing.
That finding matters because adolescence is a period of rapid brain development. Processing speed, or how quickly the brain can take in and respond to information, is one part of cognitive function. It is not the same as intelligence, academic ability or overall brain health, but it can affect how efficiently someone performs certain mental tasks.
The results suggest that metabolic health may be relevant to the developing brain, not only to future heart disease risk.
“Unfavorable blood lipid profiles can compromise cognitive function as early as adolescence. These results reinforce the evidence base for integrating cardiovascular disease prevention into broader child and adolescent health policy — what protects the heart also protects the developing brain,” said Eero Haapala, PhD, senior researcher at South-Eastern Finland University of Applied Sciences and research director at the Institute of Biomedicine, University of Eastern Finland.
The study also found more complicated relationships involving fatty acids. Higher serum concentrations of omega-3 fatty acids, omega-6 fatty acids and polyunsaturated fatty acids were associated with poorer performance on tasks requiring fast processing speed. At the same time, a more favorable ratio of omega-3 to total fatty acids was associated with better working memory.
That does not mean omega-3s are bad for the teenage brain. Instead, it shows why biomarker research can be difficult to translate into simple food advice. Blood levels of fatty acids can reflect many factors, including overall diet, metabolism, body composition, genetics and health status. A single marker may not tell the whole story.
The study drew on data from the Physical Activity and Nutrition in Children, or PANIC, study, a long-running Finnish research project focused on lifestyle, metabolism and child health. Because the new analysis was observational, it can show associations but cannot prove cause and effect. It also does not show that changing diet, lowering cholesterol or altering fatty acid intake would directly improve cognitive performance in teenagers.
That distinction is important. The findings should not be turned into a simple message that teens need a specific supplement or that one blood marker determines brain health. They are better understood as a reminder that the body’s systems are connected.
For families, the practical message is not about chasing perfect lipid numbers in healthy teenagers. It’s about supporting the same habits already linked with long-term health: balanced meals, regular physical activity, enough sleep and routine preventive care when recommended.
Those habits may matter not only for the heart teens will have decades from now, but for the developing brain they are using today.
This research was supported by Finnish public agencies, foundations and health research organizations, including the Research Council of Finland, the Ministry of Education and Culture of Finland, the Ministry of Social Affairs and Health of Finland, the Research Committee of the Kuopio University Hospital Catchment Area, Finnish Innovation Fund Sitra, the Social Insurance Institution of Finland, the Finnish Cultural Foundation, the Foundation for Paediatric Research, the Diabetes Research Foundation in Finland, the Finnish Foundation for Cardiovascular Research, the Juho Vainio Foundation, the Paavo Nurmi Foundation, the Yrjö Jahnsson Foundation and the city of Kuopio. One author also received support from the Jenny and Antti Wihuri Foundation and the Juho Vainio Foundation. Open access publication support was provided by the University of Eastern Finland, including Kuopio University Hospital.